Radiative entropy production

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/76465/1/AIAA-9535-710.pd

Entropy production in boundary layers

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/77333/1/AIAA-197-774.pd

A Novel On-chip Three-dimensional Micromachined Calorimeter with Fully Enclosed and Suspended Thin-film Chamber for Thermal Characterization of Liquid Samples

A microfabricated calorimeter (μ-calorimeter) with an enclosed reaction chamber is presented. The 3D micromachined reaction chamber is capable of analyzing liquid samples with volume of 200 nl. The thin film low-stress silicon nitride membrane is used to reduce thermal mass of the calorimeter and increase the sensitivity of system. The μ-calorimeter has been designed to perform DC and AC calorimetry, thermal wave analysis, and differential scanning calorimetry. The μ-calorimeter fabricated with an integrated heater and a temperature sensor on opposite sides of the reaction chamber allows to perform thermal diffusivity and specific heat measurements on liquid samples with same device. Measurement results for diffusivity and heat capacitance using time delay method and thermal wave analysis are presented

A realistic model of evaporation for a liquid droplet

An intuitive delineation along with dimensional considerations and experimental evidences are presented to show that in a general case, the evaporation of a liquid droplet undergoes three regimes through the process. Initially, the heat transfer inside the evaporating droplets is conduction controlled; then, in the second stage, convective heat transfer may take over; finally, the convections subside, and the process returns to conduction controlled mode

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

PrefHer revealed compelling and consistent patient preference for subcutaneous (s.c.) trastuzumab, regardless of delivery by single-use injection device or hand-held syringe. s.c. trastuzumab was well-tolerated and safety data, including immunogenicity, were consistent with previous reports. No new safety signals were identified compared with the known intravenous trastuzumab profile in early breast cance